Clinical Trial Update: DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial for HER2-positive breast cancer evaluating DV in combination with pertuzumab, with or without toripalimab; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DV
• Pertuzumab (pertuzumab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING